Prostate Theranostics and Imaging Centre of Excellence (ProsTIC) (original) (raw)
ProsTIC performs state-of-the-art research to deliver new paradigms for the treatment of prostate cancer driven by seamless integration of clinical trials, pre-clinical and discovery research
ProsTIC is made up of a multi-disciplinary team including nuclear medicine, medical oncology, radiation oncology, urology and laboratory-based doctors and researchers with a strong patient-centred philosophy. ProsTIC’s funding comes from the Prostate Cancer Foundation (PCF). Find out more about ProsTIC or follow us on X.
About ProsTIC Theranostic treatment for prostate cancer involves targeting prostate specific membrane antigen...Read more 
PSMA Theranostics Read through the following Frequently Asked Questions about PSMA theranostics:...Read more 
ProsTIC team ProsTIC Leadership Team Professor Michael Hofman - Director of Prostate Cancer Theranostics and...Read more 
Pre-clinical research and the Furic Lab One-in-seven men will be diagnosed with prostate cancer (PC) in their lifetime and PC related...Read more 
ProsTIC key research Our key publications Latest Published Research...Read more 
ProsTIC clinical trials ProsTIC clinical trials currently open LuCAB: Cabazitaxel in combination...Read more 
ProsTIC online seminars and podcasts UroToday Interviews Video link: PRINCE Trial Highlights Early Detection of Prostate Cancer...Read more 
ProsTIC Preceptorship 2026 Preceptorship: More details to be announced. The ProsTIC Preceptorship biennial event is...Read more 
ProsTIC news Our world leading research featured in the recent newsResearchers rejoice over a massive funding...Read more